Birdwatch Note Rating
2024-01-27 11:51:09 UTC - HELPFUL
Rated by Participant: 4E848634E45AD76FC76D7151C5A08556105CC2E4E4B341408CDB97A8486D4AFB
Participant Details
Original Note:
Of a total of 64 outcomes in studies of GET, NICE graded 52 (81%) as “VERY LOW” quality and 12 (19%) as “LOW” quality. It has been established that GET is not a suitable treatment for MECFS, and a significant cohort of Long Covid patients meet MECFS diagnostic criteria. https://www.nice.org.uk/guidance/gid-ng10091/documents/evidence-review-7
All Note Details